Premature Ejaculation Treatment Market
- 2026 年市場規模
- USD 3.2 Bn
- 2033 年預估規模
- USD 5.7 Bn
- 年複合成長率 CAGR
- 8.9%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Premature Ejaculation Treatment Market, By Drug Type (Selective Serotonin Reuptake Inhibitors (SSRIs) (Dapoxetine, and Others), Phosphodiesterase Type 5 (PDE5) Inhibitors (Zertane, and Others), Topical Anesthetics, and Others), By Route of Administration (Oral and Topical), By Dosage Form (Pills, Spray, and Others), By Distribution Channel (Hospitals, Online Pharmacies, and Retail Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa)
報告摘要
Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.
Market Dynamics
Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.
Key features of the study
• This report provides in-depth analysis of premature ejaculation treatment market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global premature ejaculation treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technological up-gradation, market expansion, and marketing tactics
• The global premature ejaculation treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the premature ejaculation treatment market
Market Segmentation
• By Drug Type (Revenue, USD Bn, 2021-2033)
o Selective Serotonin Reuptake Inhibitors (SSRIs)
Dapoxetine
Others
o Phosphodiesterase Type 5 (PDE5) Inhibitors
Zertane
Others
o Topical Anesthetics
o Others
• By Route of Administration (Revenue, USD Bn, 2021-2033)
o Oral
o Topical
• By Dosage Form (Revenue, USD Bn, 2021-2033)
o Pills
o Spray
o Others
• By Distribution Channel (Revenue, USD Bn, 2021-2033)
o Hospitals
o Online Pharmacies
o Retail Pharmacies
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Competitive Landscape
o Regent Pacific Group Limited
o Menarini Group
o Furiex Pharmaceuticals, Inc.
o Absorption Pharmaceuticals, LLC
o Ampio Pharmaceuticals, Inc.
o Aytu BioScience,
o NeuroHealing Pharmaceuticals Inc.
o Dong-A Pharmaceutical Co., Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Route of Administration
Market Snippet, By Dosage Form
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o PEST Analysis
o Pipeline Analysis
o Product Approval
o Product Launch
o Collaboration-Acquisition
o Porter’s Five Forces Analysis
4. Global Premature Ejaculation Treatment Market, By Drug Type, 2021 – 2033 (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Selective Serotonin Reuptake Inhibitors (SSRIs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
Segment Trends
o Dapoxetine
o Others
o Phosphodiesterase Type 5 (PDE5) Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
Segment Trends
o Zertane
o Others
o Topical Anesthetics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
5. Global Premature Ejaculation Treatment Market, By Route of Administration, 2021 – 2033 (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
6. Global Premature Ejaculation Treatment Market, By Dosage Form, 2021 – 2033 (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Pills
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Spray
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
7. Global Premature Ejaculation Treatment Market, By Distribution Channel, 2021 – 2033 (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
8. Global Premature Ejaculation Treatment Market, By Region, 2021 – 2033 (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
o North America
Market Size and Forecast, By Drug Type, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Route of Administration, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Dosage Form, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033 (USD Bn)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Drug Type, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Route of Administration, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Dosage Form, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033 (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Drug Type, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Route of Administration, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Dosage Form, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033 (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Market Size and Forecast, By Drug Type, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Route of Administration, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Dosage Form, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033 (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
Market Size and Forecast, By Drug Type, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Route of Administration, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Dosage Form, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033 (USD Bn)
o Central Africa
o South Africa
o North Africa
o Middle East
Market Size and Forecast, By Drug Type, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Route of Administration, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Dosage Form, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033 (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033 (USD Bn)
o GCC
o Israel
o Rest of Middle East
9. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Regent Pacific Group Limited
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Menarini Group
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Furiex Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Absorption Pharmaceuticals, LLC
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Ampio Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Aytu BioScience
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
NeuroHealing Pharmaceuticals Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Dong-A Pharmaceutical Co., Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
10. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 37 market data tables and 40 figures on “Premature Ejaculation Treatment Market - Global forecast to 2033”.
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們